Skip to main content
. 2020 Apr 21;18:176. doi: 10.1186/s12967-020-02328-6

Table 6.

Survival subgroups defined by survival in each treatment arm

TCV survival groups (n = 22) TC low TCV intermediate TCV high
Number of cases 9 8 5
Median overall survival (months) 9 31 60
DCV survival groups (n = 17) DCV low DCV intermediate DCV high
Number of cases 6 6 5
Median overall survival (months) 15 43 60

TCV tumor cell vaccine, DCV dendritic cell vaccine